USP22
USP22 (ubiquitin specific peptidase 22, also known as KIAA1063 or USP3L) is a deubiquitinase that removes ubiquitin from histones and other substrates. It acts in transcriptional regulation, cell cycle progression and innate immunity. Browse Assay Genie's current range of USP22 research reagents below, or read on for the biology behind the target.
USP22 is a deubiquitinase that works as part of the SAGA transcription regulatory histone acetylation (HAT) complex. In this setting it catalyses the deubiquitination of both histone H2A and histone H2B, and so acts as a transcriptional coactivator. It is recruited to specific gene promoters by activators such as MYC, where it is required for transcription.
Outside chromatin, USP22 influences cell fate and cell cycle control. It facilitates cell-cycle progression by stabilising CCNB1 and antagonising its proteasome-mediated degradation in a cell cycle-specific manner. It also modulates cell cycle progression and apoptosis by antagonising TP53 transcriptional activation through stabilisation of the deacetylase SIRT1. The NCBI Gene summary links the protein to the G2/M transition of the mitotic cell cycle, protein deubiquitination and regulation of gene expression.
USP22 has several roles in immunity and inflammation. It deubiquitinates the importin KPNA2, leading to IRF3 nuclear translocation and type I interferon production during the antiviral response. It negatively regulates STING1 activation and ubiquitination, and is described as a central regulator of type III IFN signalling. It inhibits NLRP3 inflammasome activation by promoting NLRP3 degradation through ATG5-dependent autophagy, deubiquitinates CD274 to stabilise it, and controls necroptosis by regulating RIPK3 phosphorylation and ubiquitination. During bacterial infection it targets TRAF6, removing its 'Lys-48'-linked polyubiquitination and promoting a pro-inflammatory response. USP22 belongs to the peptidase C19 family, UBP8 subfamily. Previous names include ubiquitin specific peptidase 3-like, and the mouse ortholog is Usp22.
USP22 deubiquitinates histones H2A and H2B within the SAGA complex and is recruited to promoters by activators such as MYC.
USP22 stabilises CCNB1 and SIRT1, which connects it to cell-cycle progression and to antagonism of TP53 activation.
USP22 acts on KPNA2, STING1, NLRP3 and TRAF6, shaping interferon signalling, inflammasome activation and pro-inflammatory responses.
USP22 stabilises CD274 to help maintain immune tolerance to self, and regulates RIPK3 in necroptotic cell death.
USP22 is a deubiquitinase. In the SAGA complex it removes ubiquitin from histones H2A and H2B to coactivate transcription. It also stabilises proteins such as CCNB1 and CD274, and regulates immune pathways involving STING1, NLRP3, RIPK3 and TRAF6.
The HGNC symbol is USP22, and the approved name is ubiquitin specific peptidase 22. Aliases and previous symbols include KIAA1063 and USP3L. Earlier names were ubiquitin specific protease 22 and ubiquitin specific peptidase 3-like. UniProt calls it ubiquitin carboxyl-terminal hydrolase 22.
A mouse ortholog, Usp22, is recorded for this gene. The human protein belongs to the peptidase C19 family, UBP8 subfamily, and is part of the SAGA complex. Check the datasheet of any product for its validated reactivity.
Other ubiquitin specific peptidases and deubiquitinases with research reagents at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UPT9; product specifications from Assay Genie datasheets.